• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 1-aminocycloheptane-1-carboxylic acid (CAS No. 6949-77-5)

1-aminocycloheptane-1-carboxylic acid, identified by the Chemical Abstracts Service registry number CAS No. 6949-77-5, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This bicyclic amine derivative exhibits a unique structural framework that has garnered considerable attention from researchers due to its potential applications in drug development, catalysis, and material science. The compound’s cycloheptane ring, functionalized with both an amino group and a carboxylic acid moiety, provides a versatile scaffold for further chemical modifications, making it a valuable intermediate in synthetic pathways.

The stereochemistry of 1-aminocycloheptane-1-carboxylic acid plays a pivotal role in determining its biological activity and reactivity. The presence of a single stereocenter in the cycloheptane ring allows for the existence of enantiomers, each with distinct properties. Recent studies have highlighted the importance of chirality in medicinal chemistry, emphasizing that the biological efficacy of a drug is often highly dependent on its specific stereoisomer. Consequently, 1-aminocycloheptane-1-carboxylic acid has been extensively investigated as a precursor for chiral drugs and catalysts.

In the context of pharmaceutical research, 1-aminocycloheptane-1-carboxylic acid has been explored as a building block for the synthesis of novel therapeutic agents. Its structural motif is reminiscent of several biologically active molecules, including certain neurotransmitter analogs and enzyme inhibitors. For instance, derivatives of this compound have been studied for their potential role in modulating neurotransmitter receptors, such as serotonin and dopamine receptors, which are implicated in various neurological disorders. The carboxylic acid group provides a site for further functionalization, enabling the attachment of pharmacophores that enhance binding affinity and selectivity.

Moreover, the pharmacokinetic properties of compounds derived from 1-aminocycloheptane-1-carboxylic acid have been scrutinized to optimize their bioavailability and metabolic stability. Researchers have leveraged computational modeling and high-throughput screening to identify optimal substituents that enhance solubility, permeability, and metabolic resistance. These efforts have led to the development of lead compounds with improved pharmacokinetic profiles, which are currently undergoing preclinical evaluation.

The synthetic methodologies for preparing 1-aminocycloheptane-1-carboxylic acid have also seen significant advancements. Traditional approaches often involve cyclization reactions followed by selective functionalization, but modern techniques such as transition-metal-catalyzed cross-coupling and asymmetric hydrogenation have streamlined these processes. These innovations not only improve yield but also reduce the environmental impact of synthesis. Additionally, green chemistry principles have been integrated into these synthetic routes, minimizing waste and hazardous byproducts.

In material science, 1-aminocycloheptane-1-carboxylic acid has found applications in the development of chiral polymers and liquid crystals. The incorporation of this compound into polymer backbones can impart unique optical properties, making them suitable for use in display technologies and sensor systems. Furthermore, its ability to act as a ligand in coordination chemistry has been exploited to design novel catalysts for organic transformations. These catalysts exhibit high efficiency and selectivity under mild conditions, aligning with the growing demand for sustainable chemical processes.

The biological activity of 1-aminocycloheptane-1-carboxylic acid has also been explored beyond its pharmaceutical applications. In vitro studies have demonstrated its potential as an intermediate in the synthesis of protease inhibitors, which are crucial for treating infectious diseases and cancer. The carboxylic acid group can be coupled with peptide fragments or other bioactive molecules via amide bond formation, yielding potent inhibitors with tailored specificity.

Recent advances in structure-based drug design have further highlighted the significance of 1-aminocycloheptane-1-carboxylic acid as a key intermediate. High-resolution crystal structures of target enzymes have revealed binding pockets where this compound can be strategically positioned to modulate enzyme activity. By fine-tuning its structure through rational molecular design or computational screening, researchers aim to develop drugs with enhanced efficacy and reduced side effects.

The industrial production of 1-aminocycloheptane-1-carboxylic acid has also been optimized to meet growing demand from both academic and commercial sectors. Continuous flow reactors have been employed to improve scalability while maintaining high purity standards. Additionally, process analytical technology (PAT) has been integrated into manufacturing lines to enable real-time monitoring and control, ensuring consistent product quality.

In conclusion, 1-aminocycloheptane-1-carboxylic acid (CAS No. 6949-77-5) is a multifaceted compound with broad applications across pharmaceuticals, materials science, and catalysis. Its unique structural features make it an invaluable intermediate for synthesizing biologically active molecules and functional materials. As research continues to uncover new applications for this compound, its importance in advancing chemical innovation is undeniable.

• 114781-18-9(Octanoicacid, 2-amino-2-ethyl-, (2R)-)
• 110916-84-2((R)-2-AMINO-2-METHYL-PENTANOIC ACID)
• 111717-28-3(D-Lysine, 2-methyl-)
• 105815-96-1(L-Norleucine, 2-methyl-)
• 111656-41-8(Lysine, 2-methyl-)
• 114923-78-3(Heptanoic acid,2-amino-2-methyl-, (2S)-)
• 105743-53-1(H-a-Me-Leu-OH)
• 105815-95-0(D-Norleucine, 2-methyl-)
• 160187-05-3(L-Norvaline,5-hydroxy-2-methyl-)
• 104112-34-7(L-Lysine, 2-methyl-)